No, there is no current, active FDA recall of Victoza that would remove the drug entirely from the U.S
Most recently, third-generation multi-agonists (tirzepatide, retatrutide, and survodutide) targeting complementary incretin receptors have demonstrated unprecedented metabolic efficacy, representing a paradigm shift in both diabetes and obesity management [11,12]
Noom Welcomes Rebel Wilson as Chief Wellness Ambassador to Champion Microhabits and Microdose GLP-1s Noom Welcomes Rebel Wilson as Chief Wellness Ambassador to Champion Microhabits and Microdose GLP-1s Press Release Date 09-18-2025 Noom launches microhabits free tier to make healthier living easier and more sustainable for everyone Noom is launching a national advertising campaign featuring Rebel Wilson
This promising avenue aligns with ongoing research into GHRH analogues, paving the way for innovative cognitive treatments
Lastly, we then compared them to patients that did not use GLP-1 RAs
Morillas C, DMarco L, Puchades MJ, et al